Bioniz Therapeutics bioniz.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Bioniz is a biopharmaceutical company leading the discovery and development of first-in-class multiple-cytokine inhibitory therapeutics to address immuno-inflammatory diseases and cancer, with an initial focus on orphan diseases. Bioniz leverages a world class expertise in cytokine biology, originating in research conducted at the National Institutes of Health, to create a therapeutic platform and a new generation of multiple-cytokine inhibitors with selective specificity. Selective targeting of...Show all

Bioniz is a biopharmaceutical company leading the discovery and development of first-in-class multiple-cytokine inhibitory therapeutics to address immuno-inflammatory diseases and cancer, with an initial focus on orphan diseases. Bioniz leverages a w...Show all

Company (Alive / Active)

Phone: 949-273-6000

Fax:

5 Mason St.
Suite 200
Irvine, 92618
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Bioniz Therapeutics $19.1M Apr 13, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Bioniz Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods of developing selective peptide antagonists Dec 10, 2014 May 01, 2018 Patent
Methods of developing selective peptide antagonists Jun 10, 2016 Apr 24, 2018 Patent
Compositions and methods for modulating gamma-c-cytokine activity Sep 11, 2015 Jun 13, 2017 Patent
Compositions and methods for modulating γ-c-cytokine activity Apr 23, 2013 Sep 15, 2015 Patent
Compositions and methods for modulating gamma-c-cytokine activity Jan 17, 2012 Sep 15, 2015 Patent
See all 9 patents